Skip to content
value.today

Microbio Co., Ltd.: peers

Change the peers

Microbio Co., Ltd. beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Jyong Biotech Ltd.: the market cap on file is more than 60 days old or a last known value (no market-data feed for its exchange yet), so its valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Microbio Co., Ltd., Jyong Biotech Ltd., TCM Biotech International Corp., Adimmune Corporation, PharmaEngine, Inc., Tanvex BioPharma, Inc., Sinphar Pharmaceutical Co., Ltd., TaiGen Biopharmaceuticals Holdings Limited side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureMicrobio Co., Ltd.base
4128.TWO · 🇹🇼 TW
Percentile in Consumer Defensive
Percentile in Taiwan
Jyong Biotech Ltd.
MENS · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
TCM Biotech International Corp.
4169.TWO · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
Adimmune Corporation
4142.TW · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
PharmaEngine, Inc.
4162.TWO · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
Tanvex BioPharma, Inc.
6541.TW · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
Sinphar Pharmaceutical Co., Ltd.
1734.TW · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
TaiGen Biopharmaceuticals Holdings Limited
4157.TWO · 🇹🇼 TW
Percentile in Healthcare
Percentile in Taiwan
Group median
Size
Market cap (Better neither way: ranked highest first)$195 MNov 20, 2026 · Market data2nd of 8$154 MAug 1, 2026 · Market data8th of 8$193 MNov 20, 2026 · Market data3rd of 8$193 MNov 20, 2026 · Market data4th of 8$205 MNov 20, 2026 · Market data1st of 8$181 MNov 20, 2026 · Market data5th of 8$170 MNov 20, 2026 · Market data6th of 8$162 MNov 20, 2026 · Market data7th of 8$187 M8 ranked
Net income (Higher is better)——$-5 MFY2025 · SEConly one with it————————————$-5 M—
Employees (Better neither way: ranked highest first)——27December 31, 2025 · Profileonly one with it————————————27—
Valuation
P/E ratio (Better neither way: ranked highest first)————————————193.4×price Nov 20, 2026 · Market dataonly one with it95th97th————————————————193.4×—
Price to sales (Better neither way: ranked highest first)————————————3.6×price Nov 20, 2026 · Market dataonly one with it49th68th————————————————3.6×—
Price to book (Better neither way: ranked highest first)————————————0.9×price Nov 20, 2026 · Market dataonly one with it17th22nd————————————————0.9×—
Financial strength
Interest cover (Higher is better)————-1.0×FY2025 · SEConly one with it66th—————————————————————————-1.0×—
Scorecard
Scorecard (Higher is better)——0 of 6FY2025 · Scorecardonly one with it————————————0% passed—
Growth checks (Higher is better)——0 of 1FY2025 · Scorecardonly one with it————————————0% passed—
Profitability checks (Higher is better)——0 of 1FY2025 · Scorecardonly one with it————————————0% passed—
Financial health checks (Higher is better)——0 of 3FY2025 · Scorecardonly one with it————————————0% passed—
Shareholder returns checks (Higher is better)——0 of 1FY2025 · Scorecardonly one with it————————————0% passed—
Ownership
Held by institutions (Better neither way: ranked highest first)——0.6%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it————————————0.6%—
Institutions holding (Better neither way: ranked highest first)——172026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it————————————17—
Institutional holding, change over the quarter (Better neither way: ranked highest first)——+0.0 pp2026-Q2 against 2026-Q1 · 13Fonly one with it————————————+0.0 pp—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Microbio Co., Ltd.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Jyong Biotech Ltd.: How market caps are worked out; TCM Biotech International Corp.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Adimmune Corporation: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; PharmaEngine, Inc.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Tanvex BioPharma, Inc.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; Sinphar Pharmaceutical Co., Ltd.: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close; TaiGen Biopharmaceuticals Holdings Limited: Taiwan Stock Exchange and Taipei Exchange, issued shares times the close.

Where each stands in its sector and country: P/E ratio#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

P/E ratio: each company's figure and its percentile in its sector and its country
CompanyP/E ratioIn its sectorIn its country
Microbio Co., Ltd.———
Jyong Biotech Ltd.———
TCM Biotech International Corp.———
Adimmune Corporation193.4×
95th percentile in Healthcaremedian 30.0×, 254 companies
97th percentile in Taiwanmedian 15.5×, 221 companies
PharmaEngine, Inc.———
Tanvex BioPharma, Inc.———
Sinphar Pharmaceutical Co., Ltd.———
TaiGen Biopharmaceuticals Holdings Limited———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

Fewer than two years of revenue are on file for these companies.

Rank in the group

Ranks need two fiscal years with the figure for at least two of these companies.

Suggested peers of Microbio Co., Ltd.#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Jyong Biotech Ltd.MENS · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $154 M market cap against $195 M · Same country: Taiwan · Ratios of the last two fiscal years on file
    Market cap $154 M (Aug 1, 2026)
    98 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • TCM Biotech International Corp.4169.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $193 M market cap against $195 M · Same country: Taiwan
    Market cap $193 M (Nov 20, 2026)
    95 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • Adimmune Corporation4142.TW · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $193 M market cap against $195 M · Same country: Taiwan
    Market cap $193 M (Nov 20, 2026) · revenue $54 M (year to December 2021)
    95 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • PharmaEngine, Inc.4162.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $205 M market cap against $195 M · Same country: Taiwan
    Market cap $205 M (Nov 20, 2026)
    95 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • Tanvex BioPharma, Inc.6541.TW · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $181 M market cap against $195 M · Same country: Taiwan
    Market cap $181 M (Nov 20, 2026)
    94 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • Sinphar Pharmaceutical Co., Ltd.1734.TW · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $170 M market cap against $195 M · Same country: Taiwan
    Market cap $170 M (Nov 20, 2026)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • TaiGen Biopharmaceuticals Holdings Limited4157.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $162 M market cap against $195 M · Same country: Taiwan
    Market cap $162 M (Nov 20, 2026)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Savior Lifetec Corporation4167.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $159 M market cap against $195 M · Same country: Taiwan
    Market cap $159 M (Nov 20, 2026)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    + Add
  • Polaris Group6550.TW · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $153 M market cap against $195 M · Same country: Taiwan
    Market cap $153 M (Nov 20, 2026)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    + Add
  • Sinew Pharma Inc.6634.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $151 M market cap against $195 M · Same country: Taiwan
    Market cap $151 M (last known, Jan 5, 2024)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    + Add
  • OBI Pharma, Inc.4174.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $256 M market cap against $195 M · Same country: Taiwan
    Market cap $256 M (Nov 20, 2026)
    93 of 100 (industry or sector 50 + size 28 + country 15)
    + Add
  • UnicoCell Biomed Co., Ltd.6794.TWO · 🇹🇼 Taiwan
    Same industry: Biotechnology · Similar size: $127 M market cap against $195 M · Same country: Taiwan
    Market cap $127 M (Nov 20, 2026)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.